<DOC>
	<DOCNO>NCT00645723</DOCNO>
	<brief_summary>Compare clinical efficiency evaluate treatment intravenous colistin plus inhaled colistin opposite treatment colistin intravenous plus inhaled saline solution patient VAP due baumannii carbapenems resistant .</brief_summary>
	<brief_title>Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin VAP Due MDR Acinetobacter Baumannii</brief_title>
	<detailed_description>Compare clinical efficiency evaluate treatment intravenous colistin plus inhaled colistin opposite treatment colistin intravenous plus inhaled saline solution patient VAP due baumannii carbapenems resistant .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>Diagnose VAP due A. baumannii A. baumannii another microorganism carbapenems resistant . Clinical Pulmonary Infection Score ( CPIS ) &gt; 6 Allergy colistin . Asthma Shock status Diagnose VAP due A. baumannii colistin resistant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Acinetobacter baumanii</keyword>
	<keyword>Ventilator-associated pneumonia</keyword>
</DOC>